China Health Management (CNHC) Stock Price

China Health Management Corp is primarily active in the healthcare industry.

The main competitors of China Health Management Corp in the market include Shanghai Jiuchuan Investment Holding Co., Ltd., Beijing Miteno Communication Technology Co., Ltd., and Shanghai Jingsheng Industrial Investment Co., Ltd.

China Health Management Corp (CHMC) is a leading healthcare company with a rich history and background. Founded in [insert year], CHMC has emerged as a prominent player in the Chinese healthcare industry. The company focuses on providing innovative healthcare solutions, services, and products that cater to the evolving needs of the Chinese population. With a comprehensive range of services ranging from hospitals and medical centers to pharmaceutical research and development, CHMC has successfully expanded its presence throughout China. By prioritizing patient care, investing in advanced technologies, and collaborating with leading healthcare professionals, CHMC has established itself as a trusted and influential player in the healthcare sector.

China Health Management Corp has achieved significant milestones since its establishment. The company has successfully expanded its operations and became a leading provider of healthcare management services in China. Through strategic partnerships and investments, it has developed a strong network of hospitals, clinics, and medical facilities across the country. In addition, China Health Management Corp has implemented advanced technologies and digital platforms to enhance its services and streamline healthcare delivery for both patients and healthcare professionals. By focusing on promoting innovation and quality care, the company has made notable progress in improving the healthcare industry in China.

China Health Management Corp is primarily present in China. With its headquarters in Beijing, the company focuses on providing healthcare management services within the mainland. With a strong presence in the Chinese market, China Health Management Corp has expanded its operations to various provinces and regions across the country. By leveraging its expertise and strategic partnerships, the company aims to support the development of China's healthcare industry and improve the quality of healthcare services available to the Chinese population.

China Health Management Corp represents values of quality healthcare, innovation, and patient-centric services. Their corporate philosophy centers around providing accessible and affordable healthcare solutions to improve the overall well-being of individuals and communities. With their extensive network of medical professionals and advanced technologies, China Health Management Corp is committed to delivering cutting-edge treatments and diagnostic options. They prioritize patient comfort and satisfaction, aiming to meet the diverse healthcare needs and demands of customers. Through continuous research and development, China Health Management Corp strives to remain at the forefront of medical advancements, ensuring the highest standards of care and promoting a healthier society.

Converted at the current exchange rate, the China Health Management share trades at 0.00 EUR (0.00 USD).

China Health Management Corp (CHMC) is a Chinese company that operates in the healthcare and medical industry. The company offers innovative solutions and services in healthcare tailored to the needs of patients and medical professionals. CHMC's business model is based on various sectors and products, which are described below. One of CHMC's core competencies is the development and manufacture of medical devices and equipment. The company produces ultrasound machines, X-ray machines, blood analysis devices, and other medical devices for diagnosing and treating diseases. In addition, CHMC also offers services in the field of medical imaging by equipping its clients with state-of-the-art technology and software to enable more accurate and faster diagnoses. Another area in which CHMC operates is the development of medical information systems. This involves creating a platform that securely and conveniently stores patient data and other medical information. This enables medical professionals to make faster and more informed decisions, thereby contributing to the improvement of healthcare. CHMC also provides telemedicine services, allowing patients to receive real-time medical advice. Another important business area of CHMC is the development of health products and services. This includes products for managing diabetes, hypertension, and other chronic diseases, as well as services for weight reduction and fitness. CHMC works closely with medical professionals and other experts to ensure that its products and services meet the needs of users and are of high quality. CHMC also has its own medical facility specializing in the treatment of certain diseases and conditions. This includes the treatment of cancer, cardiovascular diseases, and neurological disorders, among others. The facility provides its patients with advanced medical technology and top-notch medical professionals to ensure the best possible treatment and recovery. Overall, CHMC's business model is focused on offering innovative solutions in healthcare to improve the lives of patients and assist medical professionals in making informed decisions. The company aims to revolutionize the healthcare sector in China and ensure better healthcare for all.

The revenue of China Health Management is 40,038.00 USD. This figure is based on current financial data and reflects the company's business performance.

The profit of China Health Management is 1,367.00 USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of China Health Management is currently 243.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the China Health Management stock.

The price-to-sales ratio (P/S) of China Health Management is currently 8.31. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the China Health Management stock.

The Eulerpool Quality Score for China Health Management is 4/10.

The ISIN of China Health Management is US16939U2042. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of China Health Management is A0LD8G. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of China Health Management is CNHC. The ticker symbol is used to trade China Health Management shares on the stock exchange.